#New York

New York State Medicaid recently removed prior authorization requirements for new hep C patients, increasing opportunities for individuals.

New York collaborators will also address the related epidemics of hepatitis C, sexually transmitted infections and opioid use.

This includes New York inmates who are older, sick, pregnant or have serious respiratory conditions or compromised immune systems.

Just under 1% of pregnant women in the state overall up to 2% in central and western New York have hep C antibodies.

A new lawsuit accuses the imprisoned hedge funder of blocking generic rivals of an AIDS-related drug.

The ambitious plan will allocate an initial $5 million to help ramp up treatment, remove barriers to care and increase harm reduction.

The World Health Organization wants to see 90 percent of the world’s population screened for hepatitis C by 2030.

The plan aims to increase treatment access and expand outreach programs to those most at risk of infection.

State laws that mandate health care providers to offer hepatitis C virus (HCV) testing can help significantly increase screening rates.

The nonpartisan body will tackle a range of issues affecting Asian American and Pacific Islander communities.

Widespread treatment offers the possibility of eliminating hepatitis C as a public health threat.

The meeting aims to create a framework for eliminating the virus across New York, similar to the HIV/AIDS Ending the Epidemic Blueprint.

The deals are part of an ongoing push by the state attorney general to end discriminatory selection processes.

The move comes just over a month after Schneiderman’s office issued subpoenas to all major commercial plans in the state.

Subpoenas have been sent to all major commercial plans in the state, requesting clear documentation on how people are selected for approval.

Reports also show that HCV spending varied widely from state to state.